GSK PLC News

6-K: Transaction Notification

Sep 24 11:11 ET

6-K: Gsk's Menveo Meningococcal Vaccine in New Single-Vial, Fully Liquid Presentation Receives Positive European Chmp Opinion

Sep 24 06:11 ET

6-K: Zantac (Ranitidine) Litigation - Russell and Hughes Cases

Sep 18 09:27 ET

6-K: Blenrep (Belantamab Mafodotin) Combinations in Relapsed/Refractory Multiple Myeloma Accepted for Regulatory Review in Japan

Sep 17 07:14 ET

6-K: Blenrep (Belantamab Mafodotin) in Combination Receives Breakthrough Therapy Designation in China for Treatment of Relapsed/Refractory Multiple Myeloma

Sep 13 06:31 ET

6-K: Transaction Notification

Sep 12 10:58 ET

6-K: Gsk Announces Positive Headline Data from Phase Ii Seasonal Influenza Mrna Vaccine Programme

Sep 12 06:40 ET

6-K: Zantac (Ranitidine) Litigation - Dixon Case

Sep 11 13:46 ET

6-K: GSK Change of Registered Office Address

Sep 11 10:51 ET

6-K: Gsk Provides Update on Phase I/Ii Therapeutic Herpes Simplex Virus (Hsv) Vaccine Trial

Sep 11 06:41 ET

6-K: Depemokimab Late-Breaking Data Presented at Ers Show a 54% Reduction in Severe Asthma Exacerbations

Sep 9 10:00 ET

6-K: Transaction Notification

Sep 6 11:14 ET

6-K: Gsk Announces Positive Results from Phase Iii Trial of Nucala (Mepolizumab) in Copd

Sep 6 06:20 ET

6-K: Total Voting Rights and Capital

Sep 3 06:21 ET

6-K: European Commission Approves Expanded Age Indication for Gsk's Arexvy, The First Respiratory Syncytial Virus (Rsv) Vaccine for Adults Aged 50-59 at Increased Risk

Aug 29 07:05 ET

6-K: Gsk's Nucala (Mepolizumab) Approved in Japan for Treatment of Adults with Chronic Rhinosinusitis with Nasal Polyps

Aug 28 09:27 ET

6-K: Bepirovirsen Granted Senku Designation in Japan for Chronic Hepatitis B

Aug 28 09:12 ET

6-K: Zantac (Ranitidine) Litigation - Delaware Supreme Court to Review Superior Court's Daubert Decision

Aug 28 07:32 ET

6-K: Transaction Notification

Aug 21 10:30 ET

6-K: Transaction Notification

Aug 20 10:48 ET